In Murmansk, a child with leukemia was first given modern immunotherapy
In the Murmansk regional children's clinical hospital for the first time began treatment of a child with acute lymphoblastic leukemia drug blinatumomab. Previously, children who needed such therapy had to go to federal medical centers. This was reported in the government of the Murmansk region.

In the Murmansk regional children's clinical hospital for the first time began treatment of a child with acute lymphoblastic leukemia drug blinatumomab. Previously, children who needed such therapy had to go to federal medical centers. This was reported in the government of the Murmansk region.
Blinatumomab helps the immune system recognize and destroy tumor cells. The drug is used for certain forms of acute lymphoblastic leukemia. It is administered intravenously for a long time under the supervision of doctors.
To organize treatment and training of local specialists, a hematologist from the Research Institute of Pediatric Oncology, Hematology and Transplantology named after R. M. Gorbacheva came to Murmansk. She participated in the control of therapy and provided hospital staff with training on the use of the drug and patient observation.
Now children who are prescribed such treatment for medical reasons will be able to receive it in the Murmansk region. This will allow you to undergo therapy closer to home and family, without having to go to a federal medical center for a long time.
Earlier, MK in Murmansk reported that traumatologists discussed the treatment of complex fractures at the INLET course in Murmansk.



